Literature DB >> 7127689

Carcinoid heart disease: diagnosis by two-dimensional echocardiography.

R J Howard, M Drobac, W D Rider, T J Keane, J Finlayson, M D Silver, E D Wigle, H Rakowski.   

Abstract

We prospectively studied 14 patients with the carcinoid syndrome to determine if two-dimensional echocardiography could detect the nature and extent of valvular abnormalities. Eight of the 14 patients had definite abnormalities of the right-sided cardiac valves. The tricuspid valve had a characteristic appearance, similar to previously described pathologic findings. The leaflets appeared diffusely thickened, shortened and stiff without evidence of commissural fusion. Saline contrast studies demonstrated tricuspid regurgitation, which corresponded to the severity of the tricuspid valve involvement. The pulmonary valve could only be adequately assessed in seven of 14 patients, and morphologic abnormalities similar to those in the tricuspid valve were found. Follow-up studies have shown progression of cardiac disease in six of eight patients. We conclude that two-dimensional echocardiography can detect the characteristic cardiac abnormalities in the carcinoid syndrome and may be a useful tool for following their progression.

Entities:  

Mesh:

Year:  1982        PMID: 7127689     DOI: 10.1161/01.cir.66.5.1059

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  6 in total

1.  Transoesophageal echocardiography improves the diagnostic value of cardiac ultrasound in patients with carcinoid heart disease.

Authors:  L Lundin; J Landelius; B Andrén; K Oberg
Journal:  Br Heart J       Date:  1990-09

Review 2.  Fibrosis and carcinoid syndrome: from causation to future therapy.

Authors:  Maralyn Druce; Andrea Rockall; Ashley B Grossman
Journal:  Nat Rev Endocrinol       Date:  2009-05       Impact factor: 43.330

3.  Cross sectional echocardiographic feature in carcinoid heart disease. A mechanism for tricuspid regurgitation in this syndrome.

Authors:  M K Davies; P J Lowry; W A Littler
Journal:  Br Heart J       Date:  1984-03

4.  Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs).

Authors:  John K Ramage; A Ahmed; J Ardill; N Bax; D J Breen; M E Caplin; P Corrie; J Davar; A H Davies; V Lewington; T Meyer; J Newell-Price; G Poston; N Reed; A Rockall; W Steward; R V Thakker; C Toubanakis; J Valle; C Verbeke; A B Grossman
Journal:  Gut       Date:  2011-11-03       Impact factor: 23.059

5.  Carcinoid Heart Disease: Starting From Heart Failure.

Authors:  Nicole Bertin; Serena Favretto; Francesco Pelizzo; Lucio Mos; Franco Pertoldi; Olga Vriz
Journal:  J Investig Med High Impact Case Rep       Date:  2017-06-08

6.  The association of a panel of biomarkers with the presence and severity of carcinoid heart disease: a cross-sectional study.

Authors:  Rebecca Dobson; Malcolm I Burgess; Melissa Banks; D Mark Pritchard; Jiten Vora; Juan W Valle; Christopher Wong; Carrie Chadwick; Keith George; Brian Keevil; Joanne Adaway; Joy E S Ardill; Alan Anthoney; Uschi Hofmann; Graeme J Poston; Daniel J Cuthbertson
Journal:  PLoS One       Date:  2013-09-12       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.